For the Inventor, By the Inventor

Enter inventor name

Nerviano, Italy

Federico Maria Arcamone

USPTO Granted Patents = 83

Average Co-Inventor Count = 3.7

ph-index = 14

Forward Citations = 645(Granted Patents)

Forward Citations (Not Self Cited) = 548(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Nerviano (MI), IT (1977)
Nerviano, Milan, IT (1978 - 1979)
(Milan), IT (1980)
Nerviano (Milan), IT (1977 - 1982)
Milan, IT (1977 - 1994)
Nerviano, IT (1978 - 2000)

Company Filing History:

Farmitalia Carlo Erba

Societa' Farmaceutici Italia

A. Menarini Industrie Farmaceutiche Riunite S.r.l.

4. 4 out of 140

Farmitalia Carlo Erba S.r.l.

Bristol-myers Squibb

A. Menarini Industrie Farmaceutiche Reiunite S.r.l.

Malesci Istituto Farmacobiologico S.p.a.

Bristol-meyers Squibb

A. Menarini Industrie Farmaceutice Reunite S.r.l.

Societa Farmaceutici Italia (farmitalia Carlo Erba S.p.a.)

11. 1 out of 312

Consiglio Nazionale Delle Ricerche

A. Menarini Industrie Farmaceutiche Riunite

13. 1 out of 18

Istituto Luso Farmaco D'italia

14. 2 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 1977-2000

Loading Chart...

Areas of Expertise:

Oligonucleotide-Anthracycline

Bicyclic Tachykinins

Tachykinins Antagonists

S-Fluoro-Anthracyclines

Penem Derivatives

Distamycin Derivatives

Site Specific Alkylating Agents

Anthracycline Glycosides

Antitumor Glycosides

Beta-Lactam Antibacterial Agents

Daunomycin Derivatives

Synthetic Routes to Azetidinones

83 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6160102 - Oligonucleotide-anthracycline and oligonucleotide-anthracyclinone (2000-12-12),

2. 6150325 - Bicyclic tachykinins antagonists, preparation thereof and their use in (2000-11-21),

3. 5849795 - Tachykinins antagonists (1998-12-15),

4. 5814608 - S-fluoro-anthracyclines, processes for their preparation and (1998-09-29),

5. 5807835 - 3'-Deamino-4'-deoxy-4'-amino-8-fluoroanthracyclines (1998-09-15),

6. 5760248 - Tachykinin antagonists (1998-06-02),

7. 5747483 - Penem derivatives, their preparation and pharmaceutical compositions (1998-05-05),

8. 5698710 - Tachykinins antagonists (1997-12-16),

9. 5670534 - Distamycin a derivatives as anti-malarial agents (1997-09-23),

10. 5641802 - Tachyquinine antagonists, their preparation and use in pharmaceutical (1997-06-24),

11. 5472976 - Poly 4-aminopyrrole-2-carboxyamide derivatives, and pharmaceutical (1995-12-05),

12. 5310752 - Site specific alkylating agents (1994-05-10),

13. 5138042 - 6-deoxyanthracyclines (1992-08-11),

14. 5049579 - Site specific alkylating agents (1991-09-17),

15. 5037970 - 6-deoxyanthracyclines (1991-08-06),

Title: Federico Maria Arcamone: A Pioneer in the Field of Inventing

Introduction:

Innovations and inventions have been at the heart of Federico Maria Arcamone's remarkable career. His relentless pursuit of excellence and commitment to pushing the boundaries of what is possible have established him as a true pioneer in the world of inventing.

Latest Patents:

Federico Maria Arcamone, hailing from Nerviano, Italy, is the proud holder of 83 patents. His latest patents include groundbreaking inventions such as Oligonucleotide-anthracycline and oligonucleotide-anthracyclinone - Bicyclic tachykinins antagonists. These innovations aim to revolutionize the pharmaceutical industry with novel compounds and pharmaceutical compositions.

Career Highlights:

Throughout his career, Federico Maria Arcamone has made significant contributions to the field of inventing. Having worked in renowned companies such as Farmitalia Carlo Erba S.p.A. and Societa' Farmaceutici Italia S.p.A., he has been instrumental in driving innovation and advancing the boundaries of science and technology.

Collaborations:

Federico Maria Arcamone's collaborative spirit has further enriched his journey as an inventor. Working alongside esteemed coworkers such as Sergio Penco and Luigi Bernardi, he has fostered a culture of innovation and excellence, resulting in groundbreaking inventions that have the potential to shape the future of the pharmaceutical industry.

Conclusion:

Federico Maria Arcamone's dedication to innovation, coupled with his pioneering spirit, has left an indelible mark on the world of inventing. His remarkable achievements and relentless pursuit of excellence continue to inspire generations of inventors and serve as a testament to the transformative power of innovation.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…